Two non-surgical knee OA injections that get confused all the time — and shouldn't be. Hyaluronic acid (gel, Synvisc, Euflexxa, Orthovisc, Hyalgan) replaces joint lubrication. PRP uses growth factors from your own blood to nudge healing. One is usually covered by insurance; the other is self-pay. Here's how LAOSS specialists choose.
HA replaces joint fluid. PRP recruits your own repair cells.
Both injections are in-office knee shots given over a span of weeks. Both are aimed at the same end goal — keep you active, delay or avoid replacement. But the biology underneath is completely different.
Hyaluronic acid (HA) — also called viscosupplementation and sold under the brand names Synvisc, Synvisc-One, Euflexxa, Orthovisc, Hyalgan, Supartz, Gel-One, Monovisc, and several others — is a synthetic version of the lubricating molecule your knee already makes. In an osteoarthritic knee, that natural hyaluronic acid is thinned out, shorter-chain, and less effective. The injection restores some of that cushioning and gliding function. It is FDA-approved for knee osteoarthritis and is the only one of these two that's typically covered by insurance — after you've documented a trial of conservative care (PT, NSAIDs, weight management) and X-rays consistent with OA.
Platelet-rich plasma (PRP) is biologic. We draw a small tube of your blood, spin it in a centrifuge to concentrate the platelets — the cells that release growth factors — and inject that concentrate back into the knee. The goal isn't to lubricate; it's to signal healing. The growth factors recruit repair cells and, in published trials, can quiet the inflammatory cytokines driving OA pain.
At LAOSS we offer both. The question we answer at every knee visit isn't "PRP or gel" in the abstract — it's which one (or neither) fits your knee, your insurance, your activity goals, and your timeline.
Whether it's hyaluronic acid to restore joint lubrication or PRP to stimulate healing, image-guided knee injections are a cornerstone of non-surgical OA care. This short video walks through what to expect.
Animations licensed from ViewMedica · Swarm Interactive
In an osteoarthritic knee, the cartilage thins, the synovial fluid loses its viscoelastic quality, and inflammatory cytokines (IL-1, TNF-alpha) drive much of what you feel as pain. Hyaluronic acid replaces the depleted long-chain lubricating molecules — restoring the gliding surface and, in some patients, modestly damping inflammation. PRP delivers concentrated growth factors that recruit repair cells, can suppress the pro-inflammatory signal, and may slow the catabolic cycle that's eating your cartilage. One is a replacement therapy; the other is biologic signaling. They are doing different jobs on the same joint.
There's no universal answer — but the decision usually breaks down along four axes: diagnosis, evidence, cost, and joint location.
Diagnosis. Both injections are aimed at mild-to-moderate knee osteoarthritis. For end-stage (bone-on-bone) arthritis, neither one reliably changes the trajectory and we'll say so — the conversation shifts to whether you're a candidate for partial or total knee replacement. For early OA with predominantly mechanical/lubrication symptoms — stiffness, grinding, that 'rusty hinge' feeling — HA often fits well. For mild-to-moderate OA with an inflammatory pain component in an active patient, PRP usually has the edge.
Evidence. Multiple head-to-head trials and meta-analyses suggest PRP outperforms HA for pain and function in mild-to-moderate knee OA at 6 and 12 months. The effect size for HA is real but modest. Neither injection is a cure, and roughly 20–30% of patients are non-responders to either one.
Cost. HA is FDA-approved for knee OA and typically covered by commercial insurance and Medicare once you've documented a failed trial of conservative care (PT, NSAIDs, weight management, X-rays consistent with OA). PRP is self-pay — about $500–$1,200 per injection, or roughly $1,500 for a series of three. HSA/FSA dollars are generally eligible.
Joint location. HA is FDA-approved for the knee only. PRP can be considered for many joints and for tendon conditions HA can't touch. If we're talking about a shoulder, hip, ankle, or elbow, this comparison stops being a comparison.
Most patients don't have to choose one and never touch the other. Here's how we sequence them based on which path fits your situation.
When insurance coverage is the constraint and the knee fits the FDA-approved indication — HA usually moves first.
When evidence at 6–12 months matters more than insurance coverage, or when the joint or tissue isn't a knee — PRP usually moves first.
Cost is often the deciding factor — and unlike a lot of clinics, we quote the number before you commit.
HA (Synvisc, Euflexxa, Orthovisc, Hyalgan, and others) is FDA-approved for knee osteoarthritis and is a covered orthopedic service under most commercial plans and Medicare Part B, after a documented trial of conservative care.
Most insurance plans classify PRP as investigational for orthopedic indications. We tell you the exact number before you book — no surprise billing.
Both injections build slowly. Neither is a same-day pain killer. Knowing the curve helps you plan around real life.
HA isn't a same-day pain killer. It restores lubrication over weeks, peaks in the months that follow, and the benefit typically fades around month 6.
PRP works on tissue biology, not pharmacology. The first meaningful improvement is at 2–6 weeks, peak benefit lands around 6 months, and the benefit can persist a year or more in responders.
We won't oversell PRP, and we won't dismiss HA. Here's the honest read on the orthopedic literature for knee osteoarthritis specifically.
HA has been used for knee OA for decades. The data supports a real but modest effect, with the strongest signal in mild-to-moderate disease and in lower-molecular-weight preparations.
Multiple head-to-head trials and meta-analyses have compared PRP to HA for knee OA. The signal favors PRP at 6 and 12 months — but the effect is most consistent in mild-to-moderate disease, and weaker for severe bone-on-bone arthritis.
These checklists are a starting point — the final call comes at your evaluation, with imaging and exam findings in front of us.
HA is most often the right move when the knee fits the FDA-approved indication, insurance is the practical constraint, and you've already worked through conservative care.
PRP is the better call when head-to-head evidence matters more than insurance, the joint isn't a knee, or HA has already been tried.
Both recoveries are mild and outpatient. Neither one keeps you off your feet — the bigger ask is patience while the biology builds.
HA is an in-and-out office procedure. Most patients walk out and resume normal activity the same day, with mild soreness for a day or two.
PRP triggers an inflammatory healing response. You'll feel sore for 2–4 days — that's the response working, not a complication.
PT pairs with both injections. With HA, PT helps you take advantage of restored lubrication. With PRP, PT is what locks in the tissue-level work.
Patients ask us all the time whether they can do both PRP and HA in the same knee. The honest answer is: combining them is investigational. Some published series have explored a combined preparation, but it's not standard of care and the evidence isn't mature. At LAOSS we do not routinely stack the two on the same day.
A more practical pattern: if you've completed a course of HA and the response is fading after 4–6 months — and you're trying to push further before considering surgery — it is reasonable to consider PRP as the next step rather than another HA course. Similarly, if PRP gave you a year of relief and that benefit is now fading, HA can be the next move, especially if it's covered.
There's also a third option that gets brought up at almost every knee OA visit: cortisone. It is fast, cheap, and insurance-covered — strongest evidence for short-term (4–12 week) pain relief. It calms inflammation but doesn't lubricate, repair, or change the disease trajectory. For an acute flare while you're waiting for HA or PRP to build, cortisone can be the right bridge. We avoid it in the 3 months before any planned joint replacement.
And there are situations where the right answer is neither yet — for early arthritis, structured PT, activity modification, weight management, and time often outperform either injection. We'll tell you that too.
Both injections are well-tolerated when delivered by experienced specialists under ultrasound guidance — but the risk profiles differ.
HA has decades of safety data. Risks are well-characterized and most are short-lived. Allergic reactions are rare but possible with avian-derived preparations.
Because PRP uses your own blood, allergic reaction is essentially nonexistent. The bigger considerations are cost, response variability, and NSAID timing.
Both HA and PRP at LAOSS are performed by board-certified pain management physicians with deep training in ultrasound-guided knee injection technique. PRP uses our in-house centrifuge protocol — the same physician who does your diagnostic ultrasound prepares the sample and performs the injection. No hand-offs to ancillary staff, no marketing-driven "packages." The person diagnosing is the person treating.
Dr. Acosta saved me from spine surgery. I came in convinced I was going to need an operation. He laid out a non-surgical plan that's been working. So thankful.
Book a visit at any of our eight Los Angeles-area offices. We'll examine the knee, image it on-site, and tell you straight whether PRP, hyaluronic acid, both in sequence, or neither is the right next step.
